Where is the radiobiology and pharmacology research to improve outcomes in glioblastoma?-Reference-Cited by-同舟云学术

Where is the radiobiology and pharmacology research to improve outcomes in glioblastoma?

Published:2015-05-30 Issue:1 Volume:124 Page:1-3
ISSN:0167-594X
Container-title:Journal of Neuro-Oncology
language:en
Short-container-title:J Neurooncol

Author:

Fay Michael,Head Richard,Martin Jennifer

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Neurology (clinical),Neurology,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s11060-015-1816-z.pdf

Reference19 articles.

1. Johnson DR, O’Neill BP (2012) Glioblastoma survival in the United States before and during the temozolomide era. J Neurooncol 107:359–364

2. http://www.pbsgovau/industry/listing/elements/pbac-meetings/psd/2010-11/Bevacizumab_AVASTIN_Roche_PSD_2010-11_6-2_FINALpdf;jsessionid=kon95ccgxtmk11uqjsi8cvyly/

3. http://www.nzheraldconz/hamilton-news/news/articlecfm?c_id=1503366&objectid=11418674

4. https://www.medicinesaustraliacomau/wp-content/uploads/sites/52/2013/07/131021_OIT_Roche_response_FINAL_pdf

5. Soeda A, Hara A, Kunisada T, Yoshimura S, Iwama T, Park D (2015) The evidence of glioblastoma heterogeneity. Sci Reports 5:7979

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Experimental pharmacology in precision medicine;Pharmacology Research & Perspectives;2023-10-26

2. Precision medicine‐based drug treatment individualization in oncology;British Journal of Clinical Pharmacology;2020-12-13

3. DRUG REPURPOSING—Overcoming the translational hurdles to clinical use;Pharmacology Research & Perspectives;2019-11-26

4. Blood-brain barrier crossing and breakthroughs in glioblastoma therapy;BRIT J CLIN PHARMACO;2016